New Technologies for Endoscopic Treatment of Bleeding Gastroduodenal Ulcers

Ulcer Hemorrhage Clinical Trial

Official title: New Technologies for Endoscopic Treatment of Bleeding Gastroduodenal Ulcers

Status Completed

Clinical Trial Summary

The purpose of the study was to improve treatment results of patients with bleeding gastroduodenal ulcers by endoscopic applications of autoplasma, enriched with platelets and granular sorbent aseptisorb-A.

Clinical Trial Description

The clinical study was conducted on the basis of the Voronezh city specialized Center for the treatment of patients with gastrointestinal bleeding. The study included 112 patients with ulcerative gastroduodenal bleeding. All patients were divided into two groups by random sampling: the main group (n=57 people) and the comparison group (n=55 people). In the treatment of patients of the main group (57 people), an individual approach was used with the use of granular sorbent aseptisorb-A and autoplasm enriched with platelets, in the complex endoscopic treatment of bleeding-complicated gastroduodenal ulcers (Patent Russian Federation (RF) № 2632771). In the comparison group (55 people), traditional methods of endoscopic hemostasis were used. ;

Related Conditions & MeSH terms

• Hemorrhage
• Peptic Ulcer
• Ulcer
• Ulcer Hemorrhage

• NCT number: NCT04239118
• Study type: Interventional
• Source: Voronezh N.N. Burdenko State Medical Academy
• Status: Completed
• Phase: N/A
• Start date: January 10, 2018
• Completion date: December 20, 2019